Table 1.
A. AH (4 patients) in comparison to NAFLD (13 patients) | ||||||
---|---|---|---|---|---|---|
# | Uniprot Accession | Gene name | Peptide count [Unique] | log2(AH/NAFLD) | p-value | Description |
1 | P02656 | APOC3 | 3[3] | −1.90 | < 0.0001 | Apolipoprotein C-III |
2 | P00738 | HP | 15 [7] | −1.40 | 0.0002 | Haptoglobin |
3 | P02654 | APOC1 | 3 [3] | −1.16 | 0.0005 | Apolipoprotein C-I |
4 | P01764 | IGHV3–23 | 2 [1] | 1.39 | 0.0006 | Immunoglobulin heavy variable 3–23 |
5 | P02745 | C1QA | 4 [4] | 2.13 | < 0.0001 | Complement C1q subcomponent subunit A |
6 | P01023 | A2M | 37 [34] | 2.52 | 0.0008 | Alpha-2-macroglobulin |
7 | P02746 | C1QB | 6 [6] | 2.12 | < 0.0001 | Complement C1q subcomponent subunit B |
8 | P01859 | IGHG2 | 9 [4] | 1.17 | 0.0005 | Immunoglobulin heavy constant gamma 2 |
9 | P01861 | IGHG4 | 8 [2] | 1.18 | 0.0002 | Immunoglobulin heavy constant gamma 4 |
10 | P01860 | IGHG3 | 13 [6] | 1.58 | < 0.0001 | Immunoglobulin heavy constant gamma 3 |
11 | P01857 | IGHG1 | 13 [6] | 1.48 | < 0.0001 | Immunoglobulin heavy constant gamma 1 |
B. NASH (8 patients) in comparison to SS (5 patients) | ||||||
# | Uniprot Accession | Gene name | Peptide count [Unique] | log2(SS/NASH) | p-value | Description |
1 | Q6NXT2 | H3F3C | 4 [4] | 2.11 | 0.0001 | Histone H3 3C |
2 | P16104 | H2AFX | 6 [6] | 1.91 | < 0.0001 | Histone H2AX |
3 | Q96A08 | HIST1H2BA | 4 [4] | 1.60 | 0.0010 | Histone H2B type 1-A |
4 | P01040 | CSTA | 3 [3] | −1.00 | 0.0006 | Cystatin-A |
5 | P01717 | IGLV3–25 | 4 [1] | −1.02 | 0.0015 | Immunoglobulin lambda variable 3–25 |
Significance: The current investigation revealed the difference among various types of liver disease using LC-MS/MS of exosomes enriched from human serum samples of 24 patients where the most significantly up-regulation proteins were alpha-2-macroglobulin for alcoholic hepatitis and apolipoprotein C3 for nonalcoholic fatty liver disease.